Laddar...
Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study
INTRODUCTION: The INPULSIS-ON trial demonstrated that nintedanib reduced decline in forced vital capacity (FVC) and low pulmonary function (%FVC < 50%) of patients with idiopathic pulmonary fibrosis (IPF). However, there is no sufficient evidence in real world. OBJECTIVES: Reveal the utility and...
Sparad:
| I publikationen: | Drug Des Devel Ther |
|---|---|
| Huvudupphovsmän: | , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove Medical Press
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6186773/ https://ncbi.nlm.nih.gov/pubmed/30349191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S179427 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|